Citation only
via OpenAlex
Mesenchymal Stem-Cell-Based Therapy for the Older Patient
Sarah L Griffiths, David Griffiths, Nicholas Robert Forsyth
Aging Health · 2011 · ▲ 1 citations
Abstract
Bone-marrow aspirate-derived mesenchymal stem cells (MSCs) form a core element of the vast majority of adherent, autologous stem-cell-based therapeutic clinical trials. This article explores the existing literature to determine if proposed MSC-based autologous cell therapy is suitable for use in an elderly patient population. Within the review a number of questions are asked: does the bone-marrow aspirate mononuclear cell (MNC) number, the frequency of MSC colony forming units or their proliferative potential correlate with age? Does disease state have an additional impact? Are immunophenotypes, molecular profiles or differentiation capacity linked to donor age? The answers to the above questions are essential for determining the appropriateness of elderly patients as donors and recipients for autologous MSC-based trials. Taken together, MSC yield, MNC number and proliferative potential all decrease with age while differentiation potential appears unchanged. The retention of differentiation capacity suggests that the elderly patient may be suitable for MSC-based therapy; however, only when isolation protocols are tailored in an individual-specific manner to correct for decreases in MNC number and MSC yield.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2217/ahe.11.22
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Griffiths, S.L., Griffiths, D., & Forsyth, N.R. (2011). Mesenchymal Stem-Cell-Based Therapy for the Older Patient. <em>Aging Health</em>. https://doi.org/10.2217/ahe.11.22
Vancouver
Griffiths SL, Griffiths D, Forsyth NR. Mesenchymal Stem-Cell-Based Therapy for the Older Patient. Aging Health. 2011. doi:10.2217/ahe.11.22.
BibTeX
@article{sarah2011Mesenc,
title = {Mesenchymal Stem-Cell-Based Therapy for the Older Patient},
author = {Sarah L Griffiths and David Griffiths and Nicholas Robert Forsyth},
journal = {Aging Health},
year = {2011},
doi = {10.2217/ahe.11.22},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
European Cells and Materials 2008
Open access · CC-BY
Instant stem cell therapy: Characterization and concentration of human mesenchymal stem cells in vitro
Aging and Disease 2023
Open access · CC-BY
Mesenchymal Stem Cell Senescence during Aging:From Mechanisms to Rejuvenation Strategies
Experimental Hematology 2004
Open access · OA
Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use
Libyan Journal of Medical Research 2025
Open access · CC-BY
Klotho gene transfection into mesenchymal stem cells as a potential therapy for kidney disease
World Journal of Stem Cells 2014
Open access · CC-BY
Enhancing the efficacy of mesenchymal stem cell therapy
World journal of stem cells 2026
Open access · OA